Tiny cell packages and RNA that may drive inflammation in obesity and type 2 diabetes
RNA silencing machinery in extracellular vesicle-mediated immunometabolic regulation
Researchers are looking at how small particles released by cells, carrying RNA, might cause the inflammation linked to obesity and type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11237606 on NIH RePORTER |
What this research studies
This project examines small extracellular vesicles (tiny packets cells release) and the RNA they carry, focusing on how the cell’s RNA-silencing machinery shapes those RNA cargos and how recipient cells respond. The team compares vesicle RNA from obese and lean people and uses lab models and molecular tools (including CRISPR-based approaches) to alter RNA-silencing components. They will study how these changes affect inflammatory signals and metabolic pathways that relate to developing type 2 diabetes. Human blood or body-fluid samples appear to be part of the work alongside cell and animal studies to connect lab findings to people.
Who could benefit from this research
Good fit: Ideal candidates would be people with obesity or at risk for type 2 diabetes who are willing to provide blood or other body-fluid samples, possibly including adolescents and adults.
Not a fit: People without obesity-related inflammation or those with non–metabolic forms of diabetes (for example, classic type 1 autoimmune diabetes) are less likely to see direct benefits from this work.
Why it matters
Potential benefit: If successful, this work could point to blood-based biomarkers or new molecular targets to reduce obesity-related inflammation and lower the risk of type 2 diabetes.
How similar studies have performed: Previous studies have shown extracellular vesicles carry inflammatory microRNAs in obesity, but targeting or manipulating RNA-silencing machinery in this context is a newer approach.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Nakamura, Takahisa — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Nakamura, Takahisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.